Low expression of Claudin-3, Claudin-4, and Claudin-7 (CLDN3, CLDN4, and CLDN7) is associated with 3 types of epithelial cancers: breast cancer (BRCA), STAD, and bladder cancer (BLCA). Here, CLDN3 is linked to bladder transitional cell carcinoma.